FDA repeatedly rejected safety claims made by Philips after the CPAP recall but waited to alert the public, emails show

As Philips reassured patients that millions of recalled machines were safe, internal emails show federal regulators privately told the company its testing didn’t account for the impact of long-term harm from tainted devices.